Page last updated: 2024-10-27

fluconazole and Candidiasis, Chronic Mucocutaneous

fluconazole has been researched along with Candidiasis, Chronic Mucocutaneous in 26 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Candidiasis, Chronic Mucocutaneous: A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy.

Research Excerpts

ExcerptRelevanceReference
"Fluconazole compliance was monitored electronically by using the Medication Event Monitoring Systems with 19 women receiving fluconazole at 50 mg thrice weekly for prophylaxis of recurrent mucocutaneous candidiasis."2.68Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women. ( Bettencourt, FA; Dudley, MN; Fiore, TC; Flanigan, TP; Geletko, SM; Mayer, KH; Segarra, M, 1996)
"It often causes recurrence of symptoms probably due to its antifungal resistance."1.46A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans. ( Han, X; Hu, Y; Huang, S; Liu, K; Lu, Y; Mao, Z; Wu, Z; Zhou, X, 2017)
"albicans from 23 APECED patients isolated during the years 1994 to 2004 were divided into 2 groups: fluconazole-susceptible dose-dependent (MIC, 16-32 microg/mL, 18 isolates) and fluconazole-susceptible (MIC 1.35Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis ( Perheentupa, J; Pfaller, MA; Rautemaa, R; Richardson, M; Saxén, H, 2008)
"Upon fluconazole treatment the lesions diminished notably."1.31[Diagnostic image (9). Chronic mucocutaneous candidiasis]. ( van der Meer, JW; Weemaes, CM, 2000)
"Fluconazole was effective in all three cases."1.30[Familial chronic mucocutaneous candidiasis associated with autoimmune polyendocrinopathy. Treatment with fluconazole: 3 cases]. ( Abimelec, P; Bourrat, E; Feuilhade, M; Morel, P; Rybojad, M, 1999)

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19903 (11.54)18.7374
1990's10 (38.46)18.2507
2000's8 (30.77)29.6817
2010's4 (15.38)24.3611
2020's1 (3.85)2.80

Authors

AuthorsStudies
Lietz, A1
Eckel, F1
Kiss, H1
Noe-Letschnig, M1
Farr, A1
Humbert, L1
Cornu, M1
Proust-Lemoine, E1
Bayry, J1
Wemeau, JL1
Vantyghem, MC1
Sendid, B1
Giardino, G1
Somma, D1
Cirillo, E1
Ruggiero, G1
Terrazzano, G1
Rubino, V1
Ursini, MV1
Vairo, D1
Badolato, R1
Carsetti, R1
Leonardi, A1
Puel, A1
Pignata, C1
Wang, Q1
Dufresne, SF1
Vinh, DC1
Aubin, MJ1
Hu, Y2
Lu, Y1
Huang, S1
Liu, K1
Han, X1
Mao, Z1
Wu, Z1
Zhou, X1
Rautemaa, R1
Richardson, M1
Pfaller, MA1
Perheentupa, J1
Saxén, H1
Austin, N1
Darlow, BA1
McGuire, W1
Lingelbach, A1
Seidl, HP1
Frimberger, E1
Traidl-Hoffmann, C1
Ring, J1
Hofmann, H1
Austin, NC1
Darlow, B1
Kamai, Y1
Maebashi, K1
Kudoh, M1
Makimura, K1
Naka, W1
Uchida, K1
Yamaguchi, H1
Jayasinghe, M1
Schmidt, S1
Walker, B1
Röcken, M1
Schaller, M1
Liu, X1
Hua, H1
Venkateswarlu, K1
Denning, DW1
Manning, NJ2
Kelly, SL2
Boken, DJ1
Swindells, S1
Rinaldi, MG2
Geletko, SM1
Segarra, M1
Mayer, KH1
Fiore, TC1
Bettencourt, FA1
Flanigan, TP1
Dudley, MN1
Singh, N1
Barnish, MJ1
Berman, S1
Bender, B1
Wagener, MM1
Yu, VL1
Lamb, DC1
Kelly, DE1
Burgaleta, C1
Rybojad, M1
Abimelec, P1
Feuilhade, M1
Morel, P1
Bourrat, E1
van der Meer, JW1
Weemaes, CM1
Harms, K1
Herting, E1
Schiffmann, JH1
Speer, CP1
Franklin, IM1
Elias, E1
Hirsch, C1
Hay, RJ2
Drew, RH1
Perfect, JR1
Gallis, HA1
Clayton, YM1
Smith, KJ1
Warnock, DW1
Kennedy, CT1
Johnson, EM1
Hopwood, V1
Van Cutsem, J1
Vanden Bossche, H1

Reviews

4 reviews available for fluconazole and Candidiasis, Chronic Mucocutaneous

ArticleYear
Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.
    Frontiers in immunology, 2018, Volume: 9

    Topics: Adrenal Insufficiency; AIRE Protein; Animals; Autoantibodies; Candida albicans; Candidiasis, Chronic

2018
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
    The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazol

2009
Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
    The Cochrane database of systematic reviews, 2004, Issue:1

    Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazol

2004
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidia

1995

Trials

4 trials available for fluconazole and Candidiasis, Chronic Mucocutaneous

ArticleYear
Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub-analysis of the prospective multicentre phase IIb/III Prof-001 study.
    Mycoses, 2023, Volume: 66, Issue:9

    Topics: Candidiasis, Chronic Mucocutaneous; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Male; Pr

2023
Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Chronic Mucocutaneous;

1996
Low-dose fluconazole as primary prophylaxis for cryptococcal infection in AIDS patients with CD4 cell counts of < or = 100/mm3: demonstration of efficacy in a positive, multicenter trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:6

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Chronic Mucocutan

1996
Fluconazole in the management of patients with chronic mucocutaneous candidosis.
    The British journal of dermatology, 1988, Volume: 119, Issue:5

    Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Tria

1988

Other Studies

18 other studies available for fluconazole and Candidiasis, Chronic Mucocutaneous

ArticleYear
Novel STAT1 gain-of-function mutation and suppurative infections.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2016, Volume: 27, Issue:2

    Topics: Adolescent; Candidiasis, Chronic Mucocutaneous; CD4-Positive T-Lymphocytes; Cells, Cultured; Child;

2016
Chronic mucocutaneous candidiasis presenting as Candida endophthalmitis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2016, Volume: 51, Issue:2

    Topics: Administration, Oral; Adult; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic

2016
A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
    Mycopathologia, 2017, Volume: 182, Issue:3-4

    Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Fun

2017
Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis
    Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Chronic Mucocutaneous; Dru

2008
[Chronic mucocutaneous candidosis with severe esophageal stricture].
    Mycoses, 2003, Volume: 46 Suppl 1

    Topics: Adult; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Esophageal Stenosis; Female; Fluconazo

2003
Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis.
    Microbiology and immunology, 2004, Volume: 48, Issue:12

    Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candid

2004
Successful treatment of azole-resistant chronic mucocutaneous candidosis with caspofungin.
    Acta dermato-venereologica, 2006, Volume: 86, Issue:6

    Topics: Adolescent; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Caspofungin; Drug Resistance, Fun

2006
Oral manifestation of chronic mucocutaneous candidiasis: seven case reports.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2007, Volume: 36, Issue:9

    Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; C

2007
Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug.
    FEMS microbiology letters, 1995, Sep-15, Volume: 131, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Chronic Muc

1995
Fluconazole-resistant Candida albicans.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Chro

1993
Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363.
    FEMS microbiology letters, 1997, Feb-15, Volume: 147, Issue:2

    Topics: Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Microbial;

1997
[Familial chronic mucocutaneous candidiasis associated with autoimmune polyendocrinopathy. Treatment with fluconazole: 3 cases].
    Annales de dermatologie et de venereologie, 1999, Volume: 126, Issue:1

    Topics: Adolescent; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Child; Chromosome Aberrations; Ch

1999
[Diagnostic image (9). Chronic mucocutaneous candidiasis].
    Nederlands tijdschrift voor geneeskunde, 2000, Oct-28, Volume: 144, Issue:44

    Topics: Adolescent; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Fluconazole; Foot; Humans; Male;

2000
[Candida infections in premature infants weighing less than 1,500 g. Mucocutaneous colonization and incidence of systemic infections].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1992, Volume: 140, Issue:9

    Topics: Candidiasis, Chronic Mucocutaneous; Cesarean Section; Cross Infection; Cross-Sectional Studies; Drug

1992
Fluconazole-induced jaundice.
    Lancet (London, England), 1990, Sep-01, Volume: 336, Issue:8714

    Topics: Adult; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazole; HIV Seropositivity; Humans; Jau

1990
Fluconazole.
    The Journal of infection, 1990, Volume: 21, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Animals; Aspergillosis; Candidiasis, Chronic Mucocutaneous; Cryp

1990
Use of fluconazole in a patient with documented malabsorption of ketoconazole.
    Clinical pharmacy, 1988, Volume: 7, Issue:8

    Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fem

1988
Azole resistance in Candida albicans.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1986, Volume: 24, Issue:2

    Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous

1986